LONDON – Nyxoah SA reported positive clinical results for Genio, its lead-free, battery-less implantable neurostimulation device, showing it resulted in a significant reduction of the severity of ...
Nyxoah, a medical technology company focused on treating obstructive sleep apnea (OSA), announced that the FDA has approved its Genio system for a portion of patients with moderate to severe OSA with ...
The Genio system is now available in the US for OSA patients who meet eligibility criteria. The Food and Drug Administration (FDA) has approved the Genio ® system for the treatment of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results